Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Immunology"
DOI: 10.1007/s10875-018-0568-x
Abstract: PurposeWe aimed to report the clinical manifestations and immunological features of activated phosphatidylinositol 3-kinase δ syndrome 1 (APDS1) in a Chinese cohort. Moreover, we investigated the efficacy and safety of rapamycin therapy for Chinese patients…
read more here.
Keywords:
kinase syndrome;
report;
rapamycin;
chinese cohort ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000032816
Abstract: Rationale: Activated phosphoinositide 3-kinase δ syndrome (APDS), a recently described primary immunodeficiency,is caused by autosomal dominant mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta(PIK3CD) gene encoding the p110δ catalytic subunit of PI3Kδ (APDS1) or the…
read more here.
Keywords:
kinase syndrome;
kinase;
transplantation;
activated phosphoinositide ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2021.688022
Abstract: Activated PI3-kinase-δ syndrome 2 (APDS2) is caused by autosomal dominant mutations in the PIK3R1 gene encoding the p85α, p55α, and p50α regulatory subunits. Most diagnosed APDS2 patients carry mutations affecting either the splice donor or…
read more here.
Keywords:
magenis syndrome;
kinase syndrome;
activated pi3;
pi3 kinase ... See more keywords